PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
Alberto
Ocaña
Publikationen, an denen er mitarbeitet Alberto Ocaña (21)
2024
-
Exploring gastric cancer genetics: A turning point in common variable immunodeficiency
Journal of Allergy and Clinical Immunology: Global, Vol. 3, Núm. 2
-
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2
International Journal of Molecular Sciences, Vol. 25, Núm. 4
2023
-
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned
Journal of Hematology and Oncology, Vol. 16, Núm. 1
-
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
Cancers, Vol. 15, Núm. 12
-
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581
-
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
Frontiers in Immunology, Vol. 14
-
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors
International Journal of Molecular Sciences, Vol. 24, Núm. 14
2022
-
Genomic mapping of copy number variations influencing immune response in breast cancer
Frontiers in Oncology, Vol. 12
-
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates
Frontiers in Immunology, Vol. 12
2021
-
Genomic correlates of dna damage in breast cancer subtypes
Cancers, Vol. 13, Núm. 9
-
Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer
Cancers, Vol. 13, Núm. 16
-
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer
Cellular Oncology, Vol. 44, Núm. 3, pp. 569-580
-
Mapping of genomic vulnerabilities in the post-translational ubiquitination, sumoylation and neddylation machinery in breast cancer
Cancers, Vol. 13, Núm. 4, pp. 1-23
-
Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
Frontiers in Oncology, Vol. 11
2020
-
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
Frontiers in Oncology, Vol. 10
-
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
Frontiers in Oncology, Vol. 9
-
Genomic mapping identifies mutations in ryr2 and ahnak as associated with favorable outcome in basal-like breast tumors expressing pd1/pd-l1
Cancers, Vol. 12, Núm. 8, pp. 1-15
-
Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis
Molecular Diagnosis and Therapy, Vol. 24, Núm. 2, pp. 143-151
2019
-
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
Frontiers in Immunology, Vol. 10
-
Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
Frontiers in Oncology, Vol. 9